Impact of FFR After Stenting: Useful or Mere Fun Fact?

Suboptimal fractional flow reserve (FFR) results after stenting only have a moderate impact on clinical hard points but might predict a much higher risk of reintervention.

Impacto del FFR post stent ¿dato útil o solo una curiosidad?

FFR has shown a huge impact on the decision-making process when it comes to revascularizing (or not) a lesion. Its impact after angioplasty has not been fully studied, particularly in the long term. We know the thresholds before angioplasty, but should there be target values after that procedure? If FFR does not improve as much as we expected after stenting, should it be optimized, somehow?

This large-scale study included all patients who underwent FFR-guided angioplasty.

FFR was measured immediately after angioplasty and then once the operator considered the outcome as acceptable and final. These results were only observational, since no action was taken based on them.

A suboptimal result was defined as final FFR <0.90. The final endpoint was a composite of cardiac death, infarction, and any revascularization after a 2-year follow-up.

With 1000 patients included and 1165 vessels analyzed, FFR after angioplasty was <0.9 in 440 vessels (37.8%). Almost 400 patients left the cath lab with at least one vessel whose FFR was suboptimal. This accounts for over a third of the procedures; its frequency is surprising. We should remember that no action was taken based on these results.


Read also: FREEDOM with FFR: Different Outcomes?


The analysis per patient did not show a significant association between FFR results after angioplasty and combined events after 2 years of follow-up (hazard ratio [HR]: 1.08, 95% confidence interval [CI]: 0.73 to 1.60; p = 0.707). Upon consideration of each event separately, no association was found either.

The analysis per vessel offered different results. FFR <0.9 after angioplasty was associated with almost twice as many target-vessel revascularizations (HR: 1.91; 95% CI: 1.06 to 3.44; p = 0.030) and a higher risk for thrombosis.

Conclusion

Suboptimal FFR after angioplasty had no significant impact on hard cardiovascular events, but it was associated with almost twice as many target-vessel revascularizations.

CIRCINTERVENTIONS-120-009681FREE

Original Title: Impact of Poststenting Fractional Flow Reserve on Long-Term Clinical Outcomes. The FFR-SEARCH Study.

Reference: Roberto Diletti et al. Circ Cardiovasc Interv. 2021;14:e009681. DOI: 10.1161/CIRCINTERVENTIONS.120.009681.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....